Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination

被引:131
作者
Hanley, NA
Ball, SG
Clement-Jones, M
Hagan, DM
Strachan, T
Lindsay, S
Robson, S
Ostrer, H
Parker, KL
Wilson, DI
机构
[1] Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Newcastle Univ, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Univ, Dept Fetal Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] NYU, Med Ctr, Dept Pediat, Human Genet Program, New York, NY 10016 USA
[5] Univ Texas, SW Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75235 USA
基金
英国惠康基金;
关键词
steroidogenic factor 1 (SF-1); wilms' tumour 1 (WT1); sex determination; human; embryogenesis; testis; ovary;
D O I
10.1016/S0925-4773(99)00123-9
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transcription factors SF-1 and WT1 play pivotal roles in mammalian gonadal development and sexual differentiation. In human embryos, both SF-1 and WT1 are expressed when the indifferent gonadal ridge first forms at 32 days post-ovulation. As the sex cords develop - providing morphological evidence of testis differentiation - SF-1 localises predominantly to developing Sertoli cells in the sex cords, whereas WT1 retains a broader pattern of expression. Later, SF-1 localises predominantly to steroidogenic Leydig cells, and WT1 localises to the sex cords. In the ovary, SF-I and WT1 transcripts persist in the gonadal ridge from the earliest developmental stages throughout the critical period of sex determination. These studies, which delineate for the first time the sequential expression profiles of SF-1 and WT1 during human gonadal development, provide a framework for understanding human sex reversal phenotypes associated with their mutations. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 11 条
[1]   Donor splice-site mutations in WT1 are responsible for Frasier syndrome [J].
Barbaux, S ;
Niaudet, P ;
Gubler, MC ;
Grunfeld, JP ;
Jaubert, F ;
Kuttenn, F ;
Fekete, CN ;
SouleyreauTherville, N ;
Thibaud, E ;
Fellous, M ;
McElreavey, K .
NATURE GENETICS, 1997, 17 (04) :467-470
[2]  
Bullen P, 1997, BIOS, P265
[3]   Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene [J].
De Santa Barbara, P ;
Bonneaud, N ;
Boizet, B ;
Desclozeaux, M ;
Moniot, B ;
Sudbeck, P ;
Scherer, G ;
Poulat, F ;
Berta, P .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6653-6665
[4]   Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? [J].
Kikuchi, H ;
Takata, A ;
Akasaka, Y ;
Fukuzawa, R ;
Yoneyama, H ;
Kurosawa, Y ;
Honda, M ;
Kamiyama, Y ;
Hata, J .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (01) :45-48
[5]   WT-1 IS REQUIRED FOR EARLY KIDNEY DEVELOPMENT [J].
KREIDBERG, JA ;
SARIOLA, H ;
LORING, JM ;
MAEDA, M ;
PELLETIER, J ;
HOUSMAN, D ;
JAENISCH, R .
CELL, 1993, 74 (04) :679-691
[6]   A novel mammalian Wnt gene, WNT8B, shows brain-restricted expression in early development, with sharply delimited expression boundaries in the developing forebrain [J].
Lako, M ;
Lindsay, S ;
Bullen, P ;
Wilson, DI ;
Robson, SC ;
Strachan, T .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :813-822
[7]   A CELL-SPECIFIC NUCLEAR RECEPTOR IS ESSENTIAL FOR ADRENAL AND GONADAL DEVELOPMENT AND SEXUAL-DIFFERENTIATION [J].
LUO, XR ;
IKEDA, YY ;
PARKER, KL .
CELL, 1994, 77 (04) :481-490
[8]   Wilms' tumor 1 and DAX-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression [J].
Nachtigal, MW ;
Hirokawa, Y ;
Enyeart-VanHouten, DL ;
Flanagan, JN ;
Hammer, GD ;
Ingraham, HA .
CELL, 1998, 93 (03) :445-454
[9]  
O'Rahilly R., 1987, Developmental stages in human embryos
[10]   Steroidogenic factor 1: A key determinant of endocrine development and function [J].
Parker, KL ;
Schimmer, BP .
ENDOCRINE REVIEWS, 1997, 18 (03) :361-377